Longevity Biomedical (Longevity Biomedical) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of . 20)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Longevity Biomedical's net issuance of preferred for the six months ended in . 20 was $0.00 Mil. The number is 0, which means that Longevity Biomedical has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Longevity Biomedical's net issuance of preferred for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Longevity Biomedical Net Issuance of Preferred Stock Historical Data

The historical data trend for Longevity Biomedical's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Net Issuance of Preferred Stock Chart

Longevity Biomedical Annual Data

Trend

Net Issuance of Preferred Stock

Longevity Biomedical Semi-Annual Data

Net Issuance of Preferred Stock

Longevity Biomedical Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Longevity Biomedical Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines